Skip to main content

Clinuvel Pharmaceuticals Ltd

For the period ended Jun 30, 2026. Filed Oct 30, 2026.

View on SEC.gov

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2026 · Filed Oct 30, 2026

CUVL$5.10+1.6%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

CODE OF ETHICS

Item 16B. CODE OF ETHICS

Our board of directors has adopted a code of business conduct and ethics, which is applicable to all of our directors and employees. Our code of business conduct and ethics has been attached as Exhibit 11.1 to this annual report.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.